← Leaderboards
Fred R Sattler
University Of Southern California
$24,195,984
Attributed
$25,486,714
Total exposure
37
Grants
25
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–18$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$25,486,714 · 37
By mechanism
U01$13,245,401 · 2
R01$5,765,067 · 2
UM1$3,300,173 · 1
M01$3,076,996 · 20
P41$99,077 · 12
Top collaborators
- Ronald J. Ellis4 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Lashonda Y Spencer$698,531
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchSourceTestosteroneHuman SubjectResourcesHuman Therapy EvaluationResearch PersonnelAids TherapyUnited States National Institutes Of HealthGrantFundingSomatotropinHiv InfectionsAgingInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseFutureMuscle StrengthRandomizedMuscle FunctionPerformanceAdipose TissueHormone TherapyRelative (Related Person)
Grant awards (66)
Phase II trial of tesamorelin for cognition in aging HIV-infected persons$640,315
R01 · FY2018 · AG
Phase II trial of tesamorelin for cognition in aging HIV-infected persons$640,095
R01 · FY2017 · AG
Phase II trial of tesamorelin for cognition in aging HIV-infected persons$641,612
R01 · FY2016 · AG
Phase II trial of tesamorelin for cognition in aging HIV-infected persons$659,438
R01 · FY2015 · AG
UNIVERSITY OF SOUTHERN CALIFORNIA CLINICAL TRIALS UNIT$1,565,286
UM1 · FY2013 · AI · contact PI
UNIVERSITY OF SOUTHERN CALIFORNIA CLINICAL TRIALS UNIT$1,734,887
UM1 · FY2012 · AI · contact PI
UNIVERSITY OF SOUTHERN CALIFORNIA CLINICAL TRIALS UNIT$1,702,555
U01 · FY2011 · AI · contact PI
TESTOSTERONE AND GROWTH HORMONE IMPROVE BODY COMPOSITION AND$12,151
P41 · FY2011 · RR · contact PI
TESTOSTERONE THRESHOLD LEVELS AND LEAN TISSUE MASS TARGETS NEEDED$8,085
P41 · FY2011 · RR · contact PI
DURABILITY OF THE EFFECTS OF TESTOSTERONE AND GROWTH HORMONE SUPPLEMENTATION$8,085
P41 · FY2011 · RR · contact PI
WHOLE BODY AND MUSCLE PROTEIN METABOLISM ARE NOT AFFECTED BY ACUTE DEVIATIONS$8,085
P41 · FY2011 · RR · contact PI
UNIVERSITY OF SOUTHERN CALIFORNIA CLINICAL TRIALS UNIT$1,275,482
U01 · FY2010 · AI · contact PI
EVALUATION OF HIGH-PROTEIN SUPPLEMENTATION IN WEIGHT-STABLE HIV-POSITIVE$12,323
P41 · FY2010 · RR · contact PI
TESTOSTERONE AND GROWTH HORMONE IMPROVE BODY COMPOSITION AND$11,261
P41 · FY2010 · RR · contact PI
UNIVERSITY OF SOUTHERN CALIFORNIA CLINICAL TRIALS UNIT$1,924,673
U01 · FY2009 · AI · contact PI
INVESTIGATOR INITIATED STUDY OF THE EFFECTS OF ANDROGEN THERAPY ON CARBOHYDRA$71,889
M01 · FY2009 · RR · contact PI
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING (HORMA)--1 R01 AG18169-01$56,814
M01 · FY2009 · RR · contact PI
A PHASE II/III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF URIDINE$41,611
M01 · FY2009 · RR · contact PI
EVALUATION OF HIGH-PROTEIN SUPPLEMENTATION IN WEIGHT-STABLE HIV-POSITIVE$9,217
P41 · FY2009 · RR · contact PI
TESTOSTERONE AND GROWTH HORMONE IMPROVE BODY COMPOSITION AND$3,495
P41 · FY2009 · RR · contact PI
UNIVERSITY OF SOUTHERN CALIFORNIA CLINICAL TRIALS UNIT$2,031,364
U01 · FY2008 · AI · contact PI
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING (HORMA)--1 R01 AG18169-01$288,417
M01 · FY2008 · RR · contact PI
INVESTIGATOR INITIATED STUDY OF THE EFFECTS OF ANDROGEN THERAPY ON CARBOHYDRA$54,078
M01 · FY2008 · RR · contact PI
A5188: A PHASE II, PHARMACOKINETIC STUDY OF THE TRANSDERMAL CONTRACEPTIVE SYS$6,634
M01 · FY2008 · RR · contact PI
UNIVERSITY OF SOUTHERN CALIFORNIA CLINICAL TRIALS UNIT$1,530,610
U01 · FY2007 · AI · contact PI
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING (HORMA)--1 R01 AG18169-01$232,587
M01 · FY2007 · RR · contact PI
INVESTIGATOR INITIATED STUDY OF THE EFFECTS OF ANDROGEN THERAPY ON CARBOHYDRA$43,610
M01 · FY2007 · RR · contact PI
A5188: A PHASE II, PHARMACOKINETIC STUDY OF THE TRANSDERMAL CONTRACEPTIVE SYS$41,261
M01 · FY2007 · RR · contact PI
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING$5,875
P41 · FY2007 · RR · contact PI
ADULT AIDS CLINICAL TRIALS UNIT (ACTU)$1,493,171
U01 · FY2006 · AI · contact PI
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING (HORMA)--1 R01 AG18169-01$360,355
M01 · FY2006 · RR · contact PI
A PHASE III, RANDOMIZED, OPEN-LABEL COMPARISON OF LIPONAVIR/RITONAVIR PLUS$84,795
M01 · FY2006 · RR · contact PI
A5188: A PHASE II, PHARMACOKINETIC STUDY OF THE TRANSDERMAL CONTRACEPTIVE$39,367
M01 · FY2006 · RR · contact PI
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING$5,897
P41 · FY2006 · RR · contact PI
ADULT AIDS CLINICAL TRIALS UNIT (ACTU)$1,678,880
U01 · FY2005 · AI
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING$876,608
R01 · FY2005 · AG
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING (HORMA)--1 R01 AG18169-01$563,996
M01 · FY2005 · RR
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING$56,178
R01 · FY2005 · AG
TREATMENT WITH OXANDROLONE AND THE DURABILITY OF EFFECTS IN OLDER MEN$6,475
P41 · FY2005 · RR
AACTG 5112 AND 5124S/5125S SUBSTUDIES: A RANDOMIZED, CONTROLLED TRIAL OF TWO$2,149
M01 · FY2005 · RR
ADULT AIDS CLINICAL TRIALS UNIT (ACTU)$1,608,666
U01 · FY2004 · AI
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING$809,233
R01 · FY2004 · AG
Hormonal Regulators of Muscle and Metabolism In Aging$273,861
M01 · FY2004 · RR
An Investigator-Initiated, Two-Center, Randomized Trial to compare the Effects$12,899
M01 · FY2004 · RR
A RANDOMIZED DOUBLE BLIND, PLACEBO-CONTROLLED STUDY$8,597
M01 · FY2004 · RR
PROSPECTIVE, MULTICENTER, RANDOM, PLACEBO-CONTROL TRIAL$8,597
M01 · FY2004 · RR
EFFECTS OF DIFFERENT ANABOLIC STIMULI ON MUSCLE QUALITY IN AGING$8,128
P41 · FY2004 · RR
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING$779,975
R01 · FY2003 · AG
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING$661,613
R01 · FY2002 · AG
NANDROLONE DECANOATE AND RESISTANCE TRAINING FOR AUGMENTING MUSCLE$0
M01 · FY2002 · RR
ACTG313--EFFECT OF MEGASE AND TESTOSTERONE IN HIV WASTING$0
M01 · FY2002 · RR
EVALUATION OF THE ANABOLIC HORMONE SYSTEM IN PATIENTS W/HIV INFECTION$0
M01 · FY2002 · RR
EVALUATION OF THE ANABOLIC HORMONE SYSTEM IN PATIENTS W/HIV INFECTION$155,764
M01 · FY2001 · RR
ACTG313--EFFECT OF MEGASE AND TESTOSTERONE IN HIV WASTING$155,764
M01 · FY2001 · RR
NANDROLONE DECANOATE AND RESISTANCE TRAINING FOR AUGMENTING MUSCLE$155,764
M01 · FY2001 · RR
NANDROLONE DECANOATE AND RESISTANCE TRAINING FOR AUGMENTING MUSCLE$0
M01 · FY2001 · RR
EVALUATION OF THE ANABOLIC HORMONE SYSTEM IN PATIENTS W/HIV INFECTION$0
M01 · FY2001 · RR
ACTG313--EFFECT OF MEGASE AND TESTOSTERONE IN HIV WASTING$0
M01 · FY2001 · RR
NANDROLONE DECANOATE AND RESISTANCE TRAINING FOR AUGMENTING MUSCLE$155,764
M01 · FY2000 · RR
ACTG313--EFFECT OF MEGASE AND TESTOSTERONE IN HIV WASTING$155,764
M01 · FY2000 · RR
EVALUATION OF THE ANABOLIC HORMONE SYSTEM IN PATIENTS W/HIV INFECTION$35,553
M01 · FY2000 · RR
ACTG313--EFFECT OF MEGASE AND TESTOSTERONE IN HIV WASTING$35,553
M01 · FY2000 · RR
NANDROLONE DECANOATE AND RESISTANCE TRAINING FOR AUGMENTING MUSCLE$35,553
M01 · FY2000 · RR
ACTG 392: HIGH PROTEIN SUPPLEMENT IN HIV + WT LOSS PTS$0
M01 · FY2000 · RR
EVALUATION OF THE ANABOLIC HORMONE SYSTEM IN PATIENTS W/HIV INFECTION$0
M01 · FY2000 · RR
ACTG 392: HIGH PROTEIN SUPPLEMENT IN HIV + WT LOSS PTS$0
M01 · FY2000 · RR